ADIM
REPL icon

Alpha DNA Investment Management’s Replimune Group REPL Stock Holding History

Alpha DNA Investment Management’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-29
Closed -$1K – 763
2020
Q4 		$1K Buy
+29
New +$1.21K ﹤0.01% 541

Other funds holding REPL

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Alpha DNA Investment Management's REPL Position: Q1 2021 in Review

Alpha DNA Investment Management sold out of Replimune Group (REPL) in Q1 2021, closing a stake of 29 shares — an estimated $1K sold.

Alpha DNA Investment Management first reported a position in REPL in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 108 funds tracked by Wall St. Rank hold REPL as of Q1 2021.

  • Alpha DNA Investment Management reported no remaining Replimune Group position as of Q1 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 29 Replimune Group shares in Q1 2021, an estimated $1K.
  • Alpha DNA Investment Management first reported a position in Replimune Group in Q4 2020 and held it in 1 quarter.
  • Alpha DNA Investment Management's Replimune Group position peaked at $1K in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Replimune Group as of Q1 2021.

Based on Alpha DNA Investment Management's 13F filing for Q1 2021, filed 12 May 2021.